Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,186.00
Bid: 2,185.00
Ask: 2,187.00
Change: -7.00 (-0.32%)
Spread: 2.00 (0.09%)
Open: 2,195.00
High: 2,201.00
Low: 2,177.00
Yest. Close: 2,193.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Monday broker round-up - UPDATE

888 Holdings: Morgan Stanley ups target from 125p to 130p, overweight rating kept. Aggreko: Jefferies cuts target from 2,800p to 2,535p, buy rating kept; HSBC downgrades to underweight, target cut from 2,350p to 1,750p; JPMorgan Cazenove cuts target from 2,360p to 2,165p, neutral rating kept; Barcl

22 Oct 12 08:19

London close: Markets nervous ahead of Jackson Hole

- Stocks look to Jackson Hole summit for a boost - Draghi hints at action ahead of ECB meeting - Glencore leads fallers on growing opposition to merger Global stock markets were mostly trading in the red on Wednesday afternoon in spite an upwards revision to US economic growth as investors showed c

29 Aug 12 16:39

London midday: Markets look to Jackson Hole for boost

- Greece agrees on budget plan - Spain a concern as Catalonia in need of aid - Markets look ahead to Jackson Hole meeting The Footsie remained firmly in the red in morning trade as concerns over the Eurozone and speculation about the upcoming Jackson Hole meeting in Wyoming continue to be the focus

29 Aug 12 11:37

London open: Glencore leads fallers early on

- Spain a concern as Catalonia needs aid - Markets await Bernanke - Ex-div Glencore a heavy faller early on Ex-div stocks and miners were weighing heavily on the FTSE 100 index in early trading on Wednesday morning with worries about Spain weighing on sentiment. It was revealed yesterday that the

29 Aug 12 08:25

Monday broker round-up -UPDATE

AstraZeneca: JPMorgan Cazenove downgrades to underweight, target lifted from 2,800p to 2,970p. Balfour Beatty: JPMorgan Cazenove downgrades to neutral. Barclays: Citigroup reiterates buy and 330p target price. ENRC: Credit Suisse downgrades to neutral, target cut from 500p to 450p. FirstGroup: J

20 Aug 12 08:17

Friday tips round-up: Hikma, African Barrick, Lenovo

What a difference a year makes, Tempus in The Times proclaims. When the Arab Spring was in full flow, investors worried that Hikma Pharmaceuticals was too exposed to the unstable region. The company, based in Jordan, almost halved last year's sales growth forecast as governments fell. Now it looks w

17 Aug 12 06:58

Broker tips: ENRC, Hikma, Micro Focus

UBS has cut its target price for mining group Eurasian Natural Resources Corp (ENRC) from 585p to 565p after first-quarter figures came in below expectations. UBS has reduced its 2012 and 2013 EPS estimates by 4% and 7%, respectively, mainly on the back of a higher tax rate (which moderates from 20

16 Aug 12 12:10

London midday: Stocks fall despite retail data and stimulus hopes

- UK retail sales beat estimates in July - Investors eye US data - Chinese stimulus hopes increase After a pretty subdued start, the Footsie had fallen further into the red by Thursday lunchtime in spite of some better-than-expected UK retail sales data. Sales volumes rose by 0.3% during July, up

16 Aug 12 11:46

Broker snap: Jefferies hails injectables performance at Hikma

Jefferies has maintained its 'buy' rating and 860p target price for pharmaceuticals group Hikma after the firm's first-half results came in above forecasts, driven by a better-than-expected performance from the Injectables division. Group sales gained 34.8% to $532.3m in the first six months of the

16 Aug 12 11:25

Thursday broker round-up

Aegis: UBS downgrades to neutral. Babcock: Espirito Santo downgrades to neutral. Balfour Beeatty: HB Markets downgrades to hold; Deutsche Bank downgrades to hold. BG Group: Morgan Stanley downgrades to equal weight. Capital Shopping Centres: Oriel Securities upgrades to hold. Carclo: N+1 Brewin

16 Aug 12 10:06

London open: Mixed start; African Barrick jumps

- African Barrick up as China Gold shows interest - Markets continue to sift through global economic data - Wen sees 'growing room for policy operation' London's benchmark index was broadly flat on Thursday morning as investors continue to digest a raft of economic data that has been released over

16 Aug 12 08:39

London pre-open: Stimulus hopes to boost Footsie

City sources predict the FTSE 100 will open up 17 points from yesterday's close of 5,833, boosted by hopes of further economic stimulus from central banks across the globe. Overnight China revealed that its foreign direct investment declined 8.7% to $7.6bn in July, compared to the same month the p

16 Aug 12 07:26

Hikma reiterates revenue guidance

Revenue from generic drugs fell in the first half at Hikma Pharmaceuticals but branded products more than picked up the slack. Overall, revenue in the first half of 2012 rose 34.8% to $532.3m from $394.8m the year before, helped by contributions from recent acquisitions. Organic revenue growth was

16 Aug 12 07:11

Thursday preview: Hikma, PV Crystalox, retail sales

Acquisitions are set to put a gloss on the interim results of pharmaceuticals firm Hikma on Thursday. Peel Hunt is expecting the group to report sales of more than $500m, up 25% on the first half of last year when, admittedly, results had been negatively affected by the so-called Arab Spring. Sale

15 Aug 12 17:57

Wednesday broker round-up

AstraZeneca: Jefferies raises target from 2,975p to 3,100p, hold rating kept. Avon Rubber: Investec reiterates hold rating and 315p target. BTG: Jefferies maintains hold rating and 410p target. Cobham: Jefferies reiterates buy recommendation and 230p target; Investec keeps sell rating and 200p ta

8 Aug 12 09:57

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.